Jon J. Vernon

Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes

Jane Freeman, Jon J. Vernon, K. Morris et al. · Clinical Microbiology and Infection · 2014 · 270 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011–2014

Jane Freeman, Jon J. Vernon, Sally Pilling et al. · Clinical Microbiology and Infection · 2017 · 137 citations

Life Sciences, Infectious Diseases, Microbiology +17

Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study

Jane Freeman, Jon J. Vernon, Sally Pilling et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2019 · 80 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +17

A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018

Virginie Viprey, Georgina Davis, Anthony Benson et al. · Eurosurveillance · 2022 · 54 citations · Full text

Veterinary Medicine, Community Health, Infectious Diseases +17

<i>In vitro</i> susceptibility of <i>Clostridium difficile</i> to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against <i>C. difficile</i>

David F. Corbett, Andrew K. Wise, Stephen Birchall et al. · Journal of Antimicrobial Chemotherapy · 2015 · 40 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +15